These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 520404)

  • 1. Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):355-60. PubMed ID: 520404
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic availability of ergotamine tartrate in continuous medication.
    Myllylä VV; Ala-Hurula V; Arvela P; Kärki N; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():20-2. PubMed ID: 6935854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():7-9. PubMed ID: 6935862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Eur J Clin Pharmacol; 1982; 23(3):235-40. PubMed ID: 7173294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.
    Ala-Hurula V; Myllylä VV; Arvela P; Heikkilä J; Kärki N; Hokkanen E
    Eur J Clin Pharmacol; 1979 Feb; 15(1):51-5. PubMed ID: 421728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve.
    Tfelt-Hansen P; Eickhoff JH; Olesen J
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):151-6. PubMed ID: 7435199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine-induced anorectal strictures: report of five cases.
    Sayfan J
    Dis Colon Rectum; 2002 Feb; 45(2):271-2. PubMed ID: 11852344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoprofen and ergotamine in acute migraine.
    Kangasniemi P; Kaaja R
    J Intern Med; 1992 May; 231(5):551-4. PubMed ID: 1602293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of ergotamine tartrate as a suppository in migraine].
    Dalsgaard-Nielsen T
    Nord Med; 1968 Jul; 80(29):942-4. PubMed ID: 5685659
    [No Abstract]   [Full Text] [Related]  

  • 10. A new look at the use of ergotamine.
    Bradfield JM
    Drugs; 1976 Dec; 12(6):449-53. PubMed ID: 1001221
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacokinetics of ergotamine in migraine and cluster headache.
    Perrin VL
    Clin Pharmacokinet; 1985; 10(4):334-52. PubMed ID: 3899452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine.
    Bülow PM; Ibraheem JJ; Paalzow G; Tfelt-Hansen P
    Cephalalgia; 1986 Jun; 6(2):107-11. PubMed ID: 3091257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergotism. Unilateral brachial artery thrombosis secondary to ergotamine tartrate.
    Herlache J; Hoskins P; Schmidt CM
    Angiology; 1973 Jun; 24(6):369-73. PubMed ID: 4712163
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.
    Ala-Hurula V
    Eur J Clin Pharmacol; 1982; 21(5):397-402. PubMed ID: 7075645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.
    Sanders SW; Haering N; Mosberg H; Jaeger H
    Eur J Clin Pharmacol; 1986; 30(3):331-4. PubMed ID: 3732370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Br J Clin Pharmacol; 1983 Dec; 16(6):695-9. PubMed ID: 6419759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy of migraine.
    Crill WE
    Postgrad Med; 1972 Dec; 52(6):103-6. PubMed ID: 4635610
    [No Abstract]   [Full Text] [Related]  

  • 18. Low biological availability of ergotamine tartrate after oral dosing in cluster headache.
    Ekbom K; Paalzow L; Waldenlind E
    Cephalalgia; 1981 Dec; 1(4):203-7. PubMed ID: 6812961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risks related to the use of ergotamine in the therapy of hemicrania. Description of a case].
    Bocchia M; Baldini GG; Bertola G; Zorzoli C
    Recenti Prog Med; 1991; 82(7-8):390-3. PubMed ID: 1947404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rectal stenosis due to long-term therapy with ergotamine].
    Ontyd J; Erckenbrecht JF; Berges W
    Dtsch Med Wochenschr; 1989 Nov; 114(44):1702-5. PubMed ID: 2806103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.